SEC Sets Sights On Bristol-Myers In Foreign Bribery Crackdown
Bristol-Myers Squibb Co. has been subpoenaed by the U.S. Securities and Exchange Commission as part of an investigation into possible Foreign Corrupt Practices Act violations abroad, the company said Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article